These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10211432)

  • 41. Protection against Shiga Toxins.
    Kavaliauskiene S; Dyve Lingelem AB; Skotland T; Sandvig K
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28165371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spontaneous tandem amplification and deletion of the shiga toxin operon in Shigella dysenteriae 1.
    McDonough MA; Butterton JR
    Mol Microbiol; 1999 Dec; 34(5):1058-69. PubMed ID: 10594830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis.
    O'Brien AD; Tesh VL; Donohue-Rolfe A; Jackson MP; Olsnes S; Sandvig K; Lindberg AA; Keusch GT
    Curr Top Microbiol Immunol; 1992; 180():65-94. PubMed ID: 1324134
    [No Abstract]   [Full Text] [Related]  

  • 44. Shigellosis and Escherichia coli diarrhea: relative importance of invasive and toxigenic mechanisms.
    O'Brien AD; Gentry MK; Thompson MR; Doctor BP; Gemski P; Formal SB
    Am J Clin Nutr; 1979 Jan; 32(1):229-33. PubMed ID: 104615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Grigor'ev-Shiga dysentery and the current trends in its spread].
    Solodovnikov IuP; Pribylova LP
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jun; (6):119-24. PubMed ID: 782107
    [No Abstract]   [Full Text] [Related]  

  • 46. Shiga toxin: intestinal cell receptors and pathophysiology of enterotoxic effects.
    Keusch GT; Jacewicz M; Mobassaleh M; Donohue-Rolfe A
    Rev Infect Dis; 1991; 13 Suppl 4():S304-10. PubMed ID: 2047654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fecal excretion of leukotriene C4 during human disease due to Shigella dysenteriae.
    Cruz JR; Cano F; Razin E; Acheson DW; Keusch GT
    J Pediatr Gastroenterol Nutr; 1995 Feb; 20(2):179-83. PubMed ID: 7714683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High level expression of Shiga toxin B subunit of Shigella dysenteriae serotype 1 in Escherichia coli.
    Su G; Li F; Huang P; Rui X; Huang C
    Chin J Biotechnol; 1993; 9(1):49-55. PubMed ID: 8155839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Shiga bacillus infection. Experience in Los Angeles County, 1966 to 1971.
    Friedman CT; Western KA; Kamei I; Mathies AW
    JAMA; 1973 Dec; 226(13):1559-61. PubMed ID: 4587315
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical aspects of shigellosis in reference of sigmoidoscopic findings and histopathological changes of the colon.
    Kobari K
    Jpn J Med Sci Biol; 1998; 51 Suppl():S23-5. PubMed ID: 10211433
    [No Abstract]   [Full Text] [Related]  

  • 51. [The role of Shigella dysenteriae toxin formation at different stages in the forming of the cellular immune response in experimental animals].
    Nikolaeva TN; Bondarenko VM; Pronin AV
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):6-10. PubMed ID: 9245145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemic shiga bacillary dysentery in Rangoon, Burma, 1984/85.
    Tin Aye ; Aung Myo Han ; Khin Maung U
    Lancet; 1985 Jun; 1(8443):1442. PubMed ID: 2861376
    [No Abstract]   [Full Text] [Related]  

  • 53. Shiga toxins and apoptosis.
    Cherla RP; Lee SY; Tesh VL
    FEMS Microbiol Lett; 2003 Nov; 228(2):159-66. PubMed ID: 14638419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enzyme-linked immunosorbent assay for shigella toxin.
    Donohue-Rolfe A; Kelley MA; Bennish M; Keusch GT
    J Clin Microbiol; 1986 Jul; 24(1):65-8. PubMed ID: 3522627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemolytic uremic syndrome: clinical picture and bacterial connection.
    Parsonnet J; Griffin PM
    Curr Clin Top Infect Dis; 1993; 13():172-87. PubMed ID: 8397909
    [No Abstract]   [Full Text] [Related]  

  • 56. Shigella toxin(s): description and role in diarrhea and dysentery.
    Keusch GT; Donohue-Rolfe A; Jacewicz M
    Pharmacol Ther; 1981; 15(3):403-38. PubMed ID: 7048347
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins.
    O'Brien AD; Laveck GD
    Infect Immun; 1982 Mar; 35(3):1151-4. PubMed ID: 7040247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The anaerogenic serotype 147 as an etiologic agent of dysentery in Israel.
    Shmilovitz M; Kretzer B; Levy E
    Isr J Med Sci; 1974 Nov; 10(11):1425-9. PubMed ID: 4613700
    [No Abstract]   [Full Text] [Related]  

  • 59. Genomic analysis of the emergence of 20th century epidemic dysentery.
    Rohmer L; Jacobs MA; Brittnacher MJ; Fong C; Hayden HS; Hocquet D; Weiss EJ; Radey M; Germani Y; Talukder KA; Hager AJ; Kemner JM; Sims-Day EH; Matamouros S; Hager KR; Miller SI
    BMC Genomics; 2014 May; 15(1):355. PubMed ID: 24886041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells.
    Jacewicz M; Feldman HA; Donohue-Rolfe A; Balasubramanian KA; Keusch GT
    J Infect Dis; 1989 May; 159(5):881-9. PubMed ID: 2651533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.